Medicaid Medicare Research 
DAIC
JANUARY 29, 2024
milla1cf Mon, 01/29/2024 - 11:00 January 29, 2024 — The Society of Thoracic Surgeons has released late-breaking research scheduled for presentation at the 2024 Annual Meeting taking place January 27 - 29 in San Antonio. The analysis included 4,798 patients from 207 STS sites who underwent esophagectomy between 2012-2019.
DAIC
JANUARY 30, 2025
29, 2025 Researchers atOchsner Health, led byHernan Bazan, MD, DFSVS, FACS, have developed a predictive model with a 93% accuracy rate in determining whether urgent carotid-intervention patients will regain functional independence. tim.hodson Thu, 01/30/2025 - 15:31 Jan.
Cardiometabolic Health Congress
JANUARY 26, 2024
However, the complexities of state-regulated insurance, Medicare insulin caps, and insulin manufacturers’ patient assistance programs create a web of resources that is complicated to navigate. How to Get Insulin for Your Medicare Patients Medicare-lowered insulin costs are automatic and will be available at any in-network pharmacy.
Hypertension Journal
JANUARY 16, 2024
Hypertension, Volume 81, Issue 2 , Page e7-e9, February 1, 2024.
DAIC
JUNE 4, 2024
In January 2024, the Centers for Medicare and Medicaid Services (CMS) began requiring health care organizations to screen for five social factors: Food insecurity Interpersonal safety Housing insecurity Transportation Utilities The purpose of these screenings is to encourage engagement of community-based organizations with resources to address SDOH.
Cardiovascular Diabetology
JULY 7, 2024
The costs were direct total health care expenditures (out-of-pocket payments and payments by private insurance, Medicaid, Medicare, and other sources) from various sources (office-based visits, hospital outpatient, emergency room, inpatient hospital, pharmacy, home health care, and other medical expenditures).
DAIC
MAY 2, 2024
The clinical research results presented for the roll-in cohort from our CardiAMP CMI Trial highlight BioCardia’s continuing efforts to transform the treatment paradigm in refractory angina through the promise of a one-time cost effective minimally invasive autologous cell-based therapy,” said Peter Altman , President and CEO.
Expert insights. Personalized for you.
111 
Let's personalize your content